Obstetrics & Gynecology Doctors in Montclair, NJ Accepting Medicare

8 Obstetrics & Gynecology doctors found. Showing 1 - 8

Dr. Richard Demarsico, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 33 N Fullerton Ave, Montclair, NJ 07042 Phone: 973-744-2226    Fax: 973-509-0978

Faraj Touchan, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 33 N Fullerton Ave, Montclair, NJ 07042 Phone: 973-744-2226    Fax: 973-509-0978

Carol Mae Russell, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6000    Fax: 973-429-6209

Silvana Gaudino, MD Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 127 Pine St Ste 10, Montclair, NJ 07042 Phone: 973-707-2122    Fax: 973-655-9559

Elise S Carman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 127 Pine St, Suite 10, Montclair, NJ 07042 Phone: 973-655-9555    Fax: 973-655-9559

Dr. Joseph Robert Ivan, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6930    Fax: 973-429-6209

Babalola Olufemi Jinadu, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6930    Fax: 973-429-6209

Dr. Robert H O'donnell, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Bay Ave, Montclair, NJ 07042 Phone: 973-429-6930    Fax: 973-429-6209

News Archive

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer (MTC). The FDA also granted priority review status for the new drug application and set a Prescription Drug User Fee Act (PDUFA) action date of 7 January 2011.

Innovaro facilitates protein transduction technology licensing between Trojan Technologies, Trojantec

Innovaro, a comprehensive innovation solutions company, is pleased to announce that it has facilitated the completion of a licensing transaction between Trojan Technologies USA, a company recently formed by Verdant Ventures Advisors II, LLC, and Trojantec Ltd, a London and Cyprus based biopharmaceutical company.

Genworth Financial reports first-quarter 2010 net income of $212M against loss last year

Genworth Financial, Inc. today reported results for the first quarter of 2010. Net income, before provision for noncontrolling interests, was $212 million, or $0.43 per diluted share, compared with a net loss of $469 million, or $1.08 per diluted share, in the first quarter of 2009.

Female firefighters at high risk for PTSD symptoms and suicide ideation

In the heavily male-dominated firefighting profession, females seem to take on a majority of stress. Consuelo Arbona, UH professor of counseling psychology reports in the journal Occupational Medicine that one-fifth of female firefighters in a large, urban fire department experience post-traumatic stress disorder symptoms and are at higher risk of contemplating suicide than their male colleagues.

Scientists develop new way to detect and switch off ticking time bomb of liver disease

A new way of detecting liver disease decades before it can become fatal has been developed by a team of scientists at the University of Dundee and NHS Tayside.

Read more Medical News

› Verified 5 days ago